Secondary Epstein-Barr virus associated lymphoproliferative disorder developing in a patient with angioimmunoblastic T cell lymphoma on vorinostat

American Journal of Hematology

Volumn 87, Issue 9, 2012, Pages 927-928

  Smeltzer, Jacob P ^a   Viswanatha, David S ^a   Habermann, Thomas M ^a   Patnaik, Mrinal M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE; VORINOSTAT;

ADRENAL GLAND; ADULT; ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; IMMUNE DEFICIENCY; INFECTION RISK; LETTER; LYMPHADENOPATHY; LYMPHOPROLIFERATIVE DISEASE; OPPORTUNISTIC INFECTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SECONDARY EPSTEIN BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER; SKIN NODULE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADRENAL GLAND NEOPLASMS; ANTINEOPLASTIC AGENTS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; HYDROXAMIC ACIDS; IMMUNOBLASTIC LYMPHADENOPATHY; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, T-CELL; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; TREATMENT OUTCOME;

EID: 84865389751     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23271     Document Type: Letter

References (15)

1. Habermann TM. Posttransplant lymphoproliferative disorders. Cancer Treat Res. 2008; 142: 273-292.
2. Blaes A, Morrison V. Post transplant lymphoproliferative disorders following solid organ transplantation. Exp Rev Hematol 2010; 1: 35-44.
3. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO Classification of Tumors of Heamatopoietic and Lymphoid Tissues. IARC: Lyon; 2008.
4. Abruzzo LV, Rosales CM, Medeiros LJ, et al. Epstein-Barr Virus-positive B-cell lymphoproliferative disorders arision in immunodeficient patients previously treated with fludarabine for low-grade B-cll neoplasms. Am J Surg Path 2002; 26: 630-636.
5. Dayharsh GA, Loftus EV, Sandborn WJ, et al. Ebstein bar virus positive lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercapatopurine. Gastroenterology 2002; 122: 72-77.
6. Kluin-Nelemans HC, Coenen JL, Boers JE, et al. EBV-positive immunodeficiency lymphoma after alemtuzumab-CHOP therapy for peripheral T-cell lymphoma. Blood 2008; 112: 1039-1041.
7. Dogan A, Attygalle AD, Kyriakou C. Angioimmunoblastic T cell lymphoma. Br J Hem 2003; 121: 681-691.
8. Hawley RC, Cankovic M, Zarbo RJ. Angioimmunoblastic T cell lymphoma with supervening EBV associated diffuse large B cell lymphoma. Arch Path Lab Anal 2006; 130: 1207-1211.
9. Zettl A, Lee SS, Rudiger T, et al. Epstein-Barr virus-associated B-Cell lymphoproliferative disorders in angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma NOS. Am J Clin Pathol 2002; 117: 368-379.
10. Abruzzo LV, Schmidt K, Weiss LM, et al. B-cell lymphoma after angioimmunoblastic lymphadenopathy: A case with oligoclonal gene rearrangements associated with Epstein-Barr virus. Blood 1993; 82: 241-246.
11. Matsue K, Itoh M, Tsukuda K, et al. Development of Epstein -Barr virus-associated B cell lymphoma after intensive treatment of patients with angioimmunoblastic lymphadenopathy with dysproteinemia. Int J Hematol 1998; 67: 319-329.
12. Castillo JJ, Beltran BE, Bibas M, et al. Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: A multicenter study. Am J Hematol 2011; 86: 256-261.
13. Castillo JJ, Sinclair N, Stachurski D, et al. Positive HIV ELISA test, autoimmune hemolytic anemia, and generalized lymphadenopathy: A unifying diagnosis. Am J Hematol 2011; 86: 690-693.
14. Yang QX, Pei XJ, Tian XY, et al. Secondary cutaneous Epstein Barr virus associated diffuse large B cell lymphoma in a patient with angioimmunoblastic T cell lymphoma: A case report and review of the literature. Diag Path 2012; 7: 7.
15. Parker A, Bowles K, Bradley JA, et al. Management of post transplant lymphoproliferative disorders in adult solid organ transplant recipients: The BSCH and BTS guidelines. Br J Hem 2010; 149: 693-705.